NASDAQ:SLGL Sol-Gel Technologies (SLGL) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free SLGL Stock Alerts $0.94 +0.02 (+2.05%) (As of 11:56 AM ET) Add Compare Share Share Today's Range$0.86▼$0.9450-Day Range$0.82▼$1.2052-Week Range$0.79▼$4.05Volume90,676 shsAverage Volume29,092 shsMarket Capitalization$26.16 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Sol-Gel Technologies alerts: Email Address Sol-Gel Technologies MarketRank™ Stock AnalysisAnalyst RatingStrong Buy3.50 Rating ScoreUpside/Downside752.1% Upside$8.00 Price TargetShort InterestHealthy0.10% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.67) to ($0.41) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.89 out of 5 starsMedical Sector382nd out of 907 stocksPharmaceutical Preparations Industry168th out of 422 stocks 3.8 Analyst's Opinion Consensus RatingSol-Gel Technologies has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSol-Gel Technologies has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.10% of the float of Sol-Gel Technologies has been sold short.Short Interest Ratio / Days to CoverSol-Gel Technologies has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sol-Gel Technologies has recently decreased by 15.32%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSol-Gel Technologies does not currently pay a dividend.Dividend GrowthSol-Gel Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SLGL. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Sol-Gel Technologies this week, compared to 0 articles on an average week.MarketBeat FollowsOnly 3 people have added Sol-Gel Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sol-Gel Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders66.51% of the stock of Sol-Gel Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 26.18% of the stock of Sol-Gel Technologies is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Sol-Gel Technologies are expected to grow in the coming year, from ($0.67) to ($0.41) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sol-Gel Technologies is -0.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sol-Gel Technologies is -0.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSol-Gel Technologies has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Sol-Gel Technologies Stock (NASDAQ:SLGL)Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.Read More SLGL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SLGL Stock News HeadlinesApril 20, 2024 | wsj.comSol-Gel Technologies Ltd.April 15, 2024 | americanbankingnews.comSol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Down 17.8% in MarchApril 25, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItSee this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)April 1, 2024 | globenewswire.comSol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® CreamMarch 23, 2024 | investing.comSol Gel Technologies Ltd (SLGL)March 16, 2024 | finance.yahoo.comSLGL May 2024 2.500 putMarch 14, 2024 | benzinga.comSol-Gel Technologies: Q4 Earnings InsightsMarch 14, 2024 | finance.yahoo.comSol-Gel Technologies Full Year 2023 Earnings: Revenues Beat Expectations, EPS In LineApril 25, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItSee this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)March 14, 2024 | finanznachrichten.deSol-Gel Technologies Ltd.: Sol-Gel Reports Full-Year 2023 Financial Results and Corporate DevelopmentsMarch 13, 2024 | globenewswire.comSol-Gel Reports Full-Year 2023 Financial Results and Corporate DevelopmentsFebruary 28, 2024 | finance.yahoo.comSol-Gel Technologies Ltd. (SLGL) stock forecast and price targetFebruary 22, 2024 | benzinga.comSol-Gel Technologies Stock (NASDAQ:SLGL), Quotes and News SummaryDecember 9, 2023 | markets.businessinsider.comOptimistic Buy Rating for Sol-Gel Technologies on Revolutionary Topical Treatment SGT-610’s Market PotentialNovember 30, 2023 | finanznachrichten.deSol-Gel Technologies Ltd.: Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 StudyNovember 30, 2023 | finance.yahoo.comSol-Gel Technologies Screens First Patient for SGT-610 Phase 3 StudyNovember 28, 2023 | finance.yahoo.comSol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610November 20, 2023 | finance.yahoo.comIs Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Trading At A 24% Discount?November 9, 2023 | msn.comSol-Gel Technologies GAAP EPS of -$0.21 beats by $0.02, revenue of $0.21M misses by $0.48MNovember 9, 2023 | finance.yahoo.comSol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateOctober 31, 2023 | finance.yahoo.comZacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel TechnologiesOctober 10, 2023 | finance.yahoo.comIs Sol-Gel Technologies (NASDAQ:SLGL) In A Good Position To Invest In Growth?August 30, 2023 | finance.yahoo.comSol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 15, 2023 | msn.comHC Wainwright & Co. Maintains Sol-Gel Technologies (SLGL) Buy RecommendationAugust 11, 2023 | markets.businessinsider.comExpert Ratings for Sol-Gel TechnologiesAugust 10, 2023 | finance.yahoo.comSol-Gel Technologies Ltd. (SLGL) Reports Q2 Loss, Lags Revenue EstimatesAugust 10, 2023 | finance.yahoo.comSol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateSee More Headlines Receive SLGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today4/25/2024Next Earnings (Estimated)5/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:SLGL CUSIPN/A CIK1684693 Webwww.sol-gel.com Phone(728) 931-3433Fax972-153-523044444Employees36Year Founded1997Price Target and Rating Average Stock Price Target$8.00 High Stock Price Target$9.00 Low Stock Price Target$7.00 Potential Upside/Downside+769.6%Consensus RatingStrong Buy Rating Score (0-4)3.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-27,240,000.00 Net Margins-1,331.01% Pretax Margin-1,752.77% Return on Equity-61.52% Return on Assets-53.75% Debt Debt-to-Equity RatioN/A Current Ratio9.10 Quick Ratio9.10 Sales & Book Value Annual Sales$1.55 million Price / Sales16.49 Cash FlowN/A Price / Cash FlowN/A Book Value$1.67 per share Price / Book0.55Miscellaneous Outstanding Shares27,858,000Free Float9,330,000Market Cap$25.63 million OptionableOptionable Beta1.33 Social Links 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Alon Seri-Levy (Age 63)Co-Founder, CEO & Director Comp: $411kMr. Gilad Mamlok (Age 56)Chief Financial Officer Comp: $367kDr. Itzik Yosef (Age 48)Chief Operating Officer Comp: $236kMr. Moshe Arkin (Age 71)Executive Chairman of the Board Prof. David AvnirCo-FounderMs. Tamar Fishman Jutkowitz (Age 48)VP & General Counsel Dr. Karine Neimann (Age 53)VP of Projects & Planning and Chief Chemist More ExecutivesKey CompetitorsForte BiosciencesNASDAQ:FBRXAcasti PharmaNASDAQ:ACSTQilian International Holding GroupNASDAQ:QLIDURECTNASDAQ:DRRXIterum TherapeuticsNASDAQ:ITRMView All CompetitorsInstitutional OwnershipKingdon Capital Management L.L.C.Sold 91,935 shares on 3/18/2024Ownership: 2.423%View All Institutional Transactions SLGL Stock Analysis - Frequently Asked Questions Should I buy or sell Sol-Gel Technologies stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sol-Gel Technologies in the last twelve months. There are currently 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "strong buy" SLGL shares. View SLGL analyst ratings or view top-rated stocks. What is Sol-Gel Technologies' stock price target for 2024? 2 brokers have issued 1 year target prices for Sol-Gel Technologies' stock. Their SLGL share price targets range from $7.00 to $9.00. On average, they predict the company's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 752.1% from the stock's current price. View analysts price targets for SLGL or view top-rated stocks among Wall Street analysts. How have SLGL shares performed in 2024? Sol-Gel Technologies' stock was trading at $1.1050 at the beginning of the year. Since then, SLGL stock has decreased by 15.0% and is now trading at $0.9389. View the best growth stocks for 2024 here. Are investors shorting Sol-Gel Technologies? Sol-Gel Technologies saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 9,400 shares, a drop of 15.3% from the March 31st total of 11,100 shares. Based on an average daily volume of 31,300 shares, the short-interest ratio is presently 0.3 days. Approximately 0.1% of the company's shares are short sold. View Sol-Gel Technologies' Short Interest. When is Sol-Gel Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our SLGL earnings forecast. How were Sol-Gel Technologies' earnings last quarter? Sol-Gel Technologies Ltd. (NASDAQ:SLGL) released its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by $0.01. The business had revenue of $0.45 million for the quarter, compared to analysts' expectations of $0.27 million. Sol-Gel Technologies had a negative trailing twelve-month return on equity of 61.52% and a negative net margin of 1,331.01%. What other stocks do shareholders of Sol-Gel Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sol-Gel Technologies investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Flexion Therapeutics (FLXN), Iovance Biotherapeutics (IOVA), Marker Therapeutics (MRKR), Teva Pharmaceutical Industries (TEVA), Viking Therapeutics (VKTX), Verona Pharma (VRNA) and Adaptimmune Therapeutics (ADAP). When did Sol-Gel Technologies IPO? Sol-Gel Technologies (SLGL) raised $60 million in an IPO on Thursday, February 1st 2018. The company issued 5,000,000 shares at $11.00-$13.00 per share. Jefferies and BMO Capital Markets served as the underwriters for the IPO and JMP Securities and Raymond James were co-managers. How do I buy shares of Sol-Gel Technologies? Shares of SLGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SLGL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmith“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
